| GlaxoSmithKline AG - Axotide 50, Dosier-Aerosol |
| 54306 | | 04 | | Axotide 50 | | Dosier-Aerosol | | R03BA05 | | Fluticasone | | 23.11.2004 | | |
|
| Composition |
| fluticasoni propionas 50 µg, norfluranum ad aerosolum pro dosi, doses pro vase 120. |
| Packungsbestandteile |
| Metered dose aerosol | | | | | | | | Active Agent | Dose |
|---|
| Fluticasoni Propionas | 50 µg |
| | BAG: Active Agent | Dose |
|---|
| Fluticasoni-17 Propionas | 50 mcg |
| | | | Inactive agents |
|---|
| Norfluranum ad Aerosolum pro Dosi |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 032 | inhalation(s) à 0.05 mg | 7.73 | 17.65 | B | SL | No |
|
